Compare Cognizant Technology Solutions Corp (CTSH) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cognizant Technology Solutions Corp vs Moderna, Inc. — how do they compare? Cognizant Technology Solutions Corp trades at $58.36 (market cap $26.22B), while Moderna, Inc. trades at $63.5 (market cap $25.42B). The key difference: Cognizant Technology Solutions Corp and Moderna, Inc. are close in size by market cap, and Cognizant Technology Solutions Corp pays a 2.27% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| CTSH | MRNA | |
|---|---|---|
Market Cap | $26.22B | $25.42B |
Sector | Technology | Health |
52-Week High | $86.70 | $81.80 |
52-Week Low | $38.73 | $22.36 |
Enterprise Value | $27.27B | $21.57B |
Dividend Yield | 2.27% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cognizant Technology Solutions Corp
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
